Sign in
CompletedPhase 2

Exercise Plus Duloxetine for Knee Osteoarthritis

Key facts

Who runs it
University of Maryland, Baltimore
Where
Baltimore, United StatesSee the site
Trial code
Status
Completed
Phase
Phase 2
People taking part
43 people enrolled
Started
7 Oct 2021
Ended
11 Aug 2025
Type of study
Interventional
Treatments tested
  • Aerobic exercise
  • Duloxetine
Record updated
29 October 2026

Who can take part

Age
40 years and older
Sex
Women and men
Healthy volunteers
Cannot take part
Show the full registry criteria (16)Hide the full registry criteria

Who can take part

  • English speaking
  • 40 years or older
  • Symptomatic knee osteoarthritis fulfilling 1986 American College of Rheumatology criteria
  • No plan for surgical knee osteoarthritis intervention within six months of enrollment
  • Major depressive disorder satisfying diagnostic criteria according to the DSM-V
  • Ability to participate in a supervised aerobic exercise program

Who cannot take part

  • Other medications deemed by study team to endanger the health of the participant or unduly confound the results
  • Substance abuse disorder or suicidal ideation within the previous year
  • Active cancer that is currently undergoing treatment (receiving chemotherapy and/or radiation therapy)
  • Cognitive impairment (Mini-Mental State Examination score < 20)
  • Past or current bipolar disorder or psychotic symptoms according to the DSM-V
  • Not able to participate in a supervised exercise program based on the presence of unstable angina, recent MI (within last 3 months), hemiparetic gait, inability to walk at least 1mph on treadmill safely, poorly controlled hypertension (resting blood pressure > 190/110), peripheral arterial disease with current foot or leg ulcers, or cardiac or pulmonary disease with exercise tolerance NYHA class 3 or higher
  • Other conditions deemed by study team to endanger the health of the participant or unduly confound the results
  • Already performing aerobic or resistive exercise 2x/week or more
  • Taking duloxetine, antipsychotics, benzodiazepines, or opioid analgesics
  • Pregnant or lactating women

Where in United States

  • University of Maryland School of MedicineBaltimore, United States

About the trial

What the trial wants to find out

This study evaluates the addition of duloxetine to aerobic exercise in the treatment of symptomatic knee osteoarthritis and depressive symptoms in adults. All participants will receive the receive the treatment protocol, which will first be evaluated in terms of feasibility and then pilot tested.

The group in the trial

  • Aerobic exercise plus DuloxetineTreatment being tested

    Participants will have a starting duloxetine dosage of 30 mg/day and be titrated up to a daily optimal dosage of 60 mg/day as tolerated during the first 12-weeks of the study. Twelve weeks after the receipt of their prescription, participants will be evaluated for the need to increase medication dosage to 90 mg/day. After duloxetine initiation, participants will be provided an exercise prescription that includes a progressive walking program aiming to achieve 50 minutes of moderate-intensity physical activity, three times per week, over 24 weeks.

    Treatment: Aerobic exercise and Duloxetine

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
A Feasibility and Pilot Study of Combined Treatment Protocol Using Aerobic Exercise and Duloxetine in Older Adults With Symptomatic Knee Osteoarthritis and Comorbid Depression
Publications
Record updated
29 October 2026